글로벌 당뇨화 시장 – 2031년까지의 산업 동향 및 예측

당뇨병 신발 시장 분석 및 규모

당뇨병 신발은 당뇨병 환자의 예방적 발 관리에 중요한 역할을 합니다. 이 신발은 최적의 지지력, 쿠셔닝 및 착용감을 제공하도록 설계되어 압박점을 최소화하고 피부 손상, 물집 및 굳은 살의 위험을 줄이는 데 도움이 됩니다. 체중을 고르게 분산하고 마찰을 줄이는 당뇨병 신발은 당뇨병의 흔하고 심각한 합병증인 발궤양의 형성을 예방하는 데 도움이 됩니다. 이 예방적 접근 방식은 환자의 삶의 질을 향상시키고 당뇨병 발 합병증 치료와 관련된 의료비를 줄이는 데 도움이 됩니다.

글로벌 당뇨화 시장 규모는 2023년에 86억 달러로 평가되었으며, 2031년까지 145억 5천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 6.79%입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 수입/수출 분석, 가격 분석, 생산 소비 분석, 소비자 행동이 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

Diabetic shoes are specially designed footwear that provides extra depth, cushioning, and support to reduce the risk of skin breakdown and foot complications in diabetic patients. They help prevent issues such as ulcers, infections, and amputations by offering enhanced protection and comfort.

Diabetic Shoes Market Dynamics

Drivers

• Increasing Awareness among Diabetic Patients

Educational campaigns by healthcare providers, government initiatives, and non-profit organizations are informing patients about the risks of diabetic foot complications and the benefits of using specialized footwear. This heightened awareness encourages more diabetic patients to adopt preventive measures, including wearing diabetic shoes, to avoid serious conditions such as ulcers and amputations. As a result, demand for these specialized shoes is rising, supporting market growth and expansion.

• Growing Aging Population

Aging population is more prone to developing diabetes, which leads to the high risk of foot complications such as neuropathy and poor circulation. This demographic group often requires specialized footwear to mitigate these risks and maintain mobility and independence. Consequently, the growing elderly population fuels demand for diabetic shoes as a crucial component of their diabetic management regimen, with a focus on finding the best diabetic shoes. Manufacturers and retailers are, therefore compelled to cater to this expanding market segment by offering a variety of diabetic shoe options tailored to the unique needs of older individuals.

Opportunities

• Growing Healthcare Initiatives

Healthcare organizations worldwide are spearheading initiatives to address the growing burden of diabetic foot complications. These initiatives include educational campaigns, subsidy programs, and partnerships with footwear manufacturers to promote the use of diabetic shoes. Emphasizing preventive care and early intervention, these efforts aim to reduce the incidence of foot ulcers, infections, and amputations among diabetic patients. Such initiatives raise awareness about the importance of foot health and drive demand for diabetic shoes, thereby fueling market growth. Healthcare policies that prioritize foot care and provide reimbursement for diabetic footwear further incentivize patients to invest in these specialized products, contributing to market expansion.

• Growing Advancements in Technology Enhances Diabetic Shoes Appeal

Technological advancements encompass various aspects, including materials, design, and manufacturing processes. For instance, the integration of 3D scanning technology allows for precise measurements and customization, ensuring a better fit and comfort for diabetic patients. Additionally, advancements in cushioning materials and orthotic inserts enhance support and alleviate pressure points, reducing the risk of foot complications. Such technological progress improves the efficacy and functionality of diabetic shoes and enhances their appeal and adoption among consumers, driving market expansion.

Restraints/Challenges

• High Significant Expense

Diabetic shoes often incorporate advanced materials, technologies, and customization processes to meet the unique needs of diabetic patients. As a result, production costs are higher, leading to elevated retail prices. This poses affordability challenges for many consumers, particularly those with limited financial resources or inadequate insurance coverage. The high cost may deter potential buyers from investing in diabetic shoes, thereby limiting market penetration and hindering access to essential foot care for diabetic individuals, ultimately impacting their overall health outcomes.

• Regulatory Challenges

Compliance with regulations such as quality standards, safety certifications, and labeling requirements adds complexity and costs to the manufacturing process. Moreover, navigating the regulatory landscape across different regions and countries poses logistical challenges for manufacturers, especially smaller companies with limited resources. Delays in obtaining regulatory approvals can hinder product launches and market entry, limiting the availability of diabetic footwear options for patients. These regulatory barriers create obstacles for market growth and innovation in the diabetic shoes industry.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2023, Aetrex launched a new personalized footwear recommendation platform – FitStarter, developed with Heeluxe, to help retailers improve their shoe fitting service for shoppers, reduce returns, and increase customer satisfaction. This innovation is expected to enhance the global diabetic shoes market by offering better fit solutions, which is crucial for diabetic patients to prevent foot complications, thereby potentially reducing healthcare costs and boosting market growth
• In November 2023, Fyous, a custom-fit footwear brand, secured an Innovate U.K. match-funded grant of GBP 1.4 million to combat diabetic amputations. This funding will help expand their polymorphic molding technology combined with 3D scanning for custom-made footwear in healthcare. Such advancements are significant for the global diabetic shoes market as they address specific needs of diabetic patients, improve foot health, and reduce the risk of severe complications, driving demand for specialized footwear
• In February 2022, The American Diabetes Association collaborated with Dr. Comfort to take the next step in preventing and treating foot complications. This partnership highlights the importance of collaboration in the diabetic shoes market, promoting awareness and access to high-quality diabetic footwear. Such initiatives support the market by emphasizing preventive care, thereby increasing the adoption of diabetic shoes among patients to mitigate foot-related issues

Diabetic Shoes Market Scope

The market is segmented on distribution channel, end- user, and product type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Distribution Channel

• Offline
• Online

End- User

• Women
• Men
• Children

Patient Type

• Inpatient
• Outpatient

Diabetic Shoes Market Regional Analysis/Insights

The market is analysed and market size, volume information is provided by country, distribution channel, end-user, and patient type as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

유럽은 당뇨병과 밀접한 관련이 있는 비만 수치의 증가로 인해 시장을 지배할 것으로 예상됩니다. 또한 전 세계적으로 당뇨병 진단을 받는 여성의 수가 증가하여 특수 신발에 대한 수요가 증가하고 있습니다. 온라인 소매 침투율이 향상되면서 이러한 제품을 더 쉽게 구입할 수 있으며, 1인당 소득이 증가함에 따라 더 많은 소비자가 이러한 특수 건강 제품을 구매할 수 있습니다. 이러한 요소들이 모여 유럽 시장 성장을 주도합니다.

시장 보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장 규제의 변화를 제공하며, 이는 현재 및 미래 시장 추세에 영향을 미칩니다. 소비량, 생산 현장 및 양, 수입 수출 분석, 가격 추세 분석, 원자재 비용, 하류 및 상류 가치 사슬 분석과 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 당뇨병 신발 시장 점유율 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우위가 있습니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련됩니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 힐러 헬스, LLC(미국)
• 오쏘피트(미국)
• 필그림 슈즈(미국)
• 포다르티스 Srl(이탈리아)
• 프로펫 풋웨어(미국)
• 에토닉(미국)
• 에이펙스풋(미국)
• Advanced Diabetic Solutions (미국)
• DARCO 인터내셔널(미국)
• THUASNE SA(프랑스)
• SIGVARIS(스위스)
• 행거 클리닉(미국)
• Anodyne, LLC(미국)
• 페도르247(미국)
• Apis Footwear Company (미국)
• Foot Comfort Center(미국)
• 오아시스 풋웨어, LLC. (미국)
• 리드 메디컬 유한회사(영국)
• PLS Pedorthic Lab Specialties, Inc(미국)

SKU-44828